Society for Participatory Medicine

FEBRUARY 1, 2023

This activity sent pharma and biotech companies scrambling to hire DE&I officers and related patient advocacy, engagement, and experience personnel as they came to terms with this foreign notion of actually collaborating with real, live patients. After this, patients will anxiously await implementation of the series.

BioTech 144

BioTech Drug Development Meaningful Use Pharmaceuticals 144

Lloyd Price

SEPTEMBER 2, 2023

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

Life Science 63

Life Science Digital Health EHR BioTech 63

Healthcare IT Today

JANUARY 8, 2024

The excitement around new tools took hold of all industries in 2023, and the potential is expansive. In 2023, Pear Therapeutics filed for bankruptcy and Akili abandoned the prescription business model. Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs).

Health IT 101

Health IT Drug Development Pharmaceuticals BioTech 101